Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 16.75 INR
Change Today +1.40 / 9.12%
Volume 95.2K
CF On Other Exchanges
Symbol
Exchange
Natl India
As of 7:08 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

gufic biosciences ltd (CF) Snapshot

Open
15.35
Previous Close
15.35
Day High
17.65
Day Low
15.30
52 Week High
09/16/14 - 23.50
52 Week Low
05/15/14 - 5.50
Market Cap
1.3B
Average Volume 10 Days
55.9K
EPS TTM
0.55
Shares Outstanding
77.4M
EX-Date
09/18/14
P/E TM
30.5x
Dividend
0.05
Dividend Yield
0.30%
Current Stock Chart for GUFIC BIOSCIENCES LTD (CF)

Related News

No related news articles were found.

gufic biosciences ltd (CF) Related Businessweek News

No Related Businessweek News Found

gufic biosciences ltd (CF) Details

Gufic Biosciences Limited manufactures and sells formulations, bulk drugs, and consumer products in India and internationally. The company offers products in various therapeutic segments, including anti-infectives, orthopedic disorders, gynecological disorders, and gastrointestinal disorders. The company develops formulations in various dosage forms, such as tablets, capsules, ointments, creams, gels, liquid syrups, suspensions, emulsions, lotions, solid and liquid injectables, etc. It also provides APIs in the areas of anesthetics, antifungals, anthelmintic, anti-Alzheimer’s, and anti-inflammatory. In addition, the company offers herbal/ayurvedic, consumer, and personal hygiene products, as well as hybrid vegetable seeds. Gufic Biosciences Limited was incorporated in 1984 and is based in Mumbai, India.

Founded in 1984

gufic biosciences ltd (CF) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: 1.5M
Executive Whole Time Director, Member of Audi...
Total Annual Compensation: 86.4K
Compensation as of Fiscal Year 2014.

gufic biosciences ltd (CF) Key Developments

Gufic Biosciences Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Gufic Biosciences Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 342.319 million compared to INR 313.089 million a year ago. Profit from operations before other income, finance cost & exceptional items was INR 23.856 million compared to INR 24.801 million a year ago. Profit from ordinary activities before tax was INR 13.568 million compared to INR 15.558 million a year ago. Net profit was INR 6.766 million compared to INR 10.663 million a year ago. Earnings per share were INR 0.09 compared to INR 0.14 a year ago. For the nine months, the company reported net sales/income from operations (net of excise duty) of INR 1,159.505 million compared to INR 856.925 million a year ago. Profit from operations before other income, finance cost & exceptional items was INR 85.496 million compared to INR 70.33 million a year ago. Profit from ordinary activities before tax was INR 55.265 million compared to INR 42.871 million a year ago. Net profit was INR 30.55 million compared to INR 30.093 million a year ago. Earnings per share were INR 0.39 compared to INR 0.39 a year ago.

Gufic Biosciences Ltd. to Report Q3, 2015 Results on Feb 13, 2015

Gufic Biosciences Ltd. announced that they will report Q3, 2015 results on Feb 13, 2015

Gufic Biosciences Ltd., Board Meeting, Feb 13, 2015

Gufic Biosciences Ltd., Board Meeting, Feb 13, 2015. Agenda: To discuss and approve standalone unaudited financial results of the company for the third quarter and nine months ended December 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CF:IN 16.75 INR +1.40

CF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CF.
View Industry Companies
 

Industry Analysis

CF

Industry Average

Valuation CF Industry Range
Price/Earnings 27.5x
Price/Sales 0.7x
Price/Book 4.7x
Price/Cash Flow 14.6x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUFIC BIOSCIENCES LTD, please visit www.guficbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.